Ana Martínez de Aragón
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Ana Martínez de Aragón has a total of 224 co-authors. Here are the top co-authors by number of shared publications:
- Ana Camacho-Salas
Paediatric Neurology Section, Hospital Universitario 12 de Octubre, Madrid, Spain
10 shared publications Elena Martín-Hernández
Unidad Pediátrica de Enfermedades Raras, Enfermedades Mitocondriales y Metabólicas Hereditarias, Hospital 12 de Octubre, Madrid, Spain
5 shared publications- Francisco Martínez-Azorín
Grupo de Enfermedades Raras, Mitocondriales y Neuromusculares (ERMN), Instituto de Investigación Hospital 12 de Octubre (imas12), Madrid, Spain
5 shared publications - María Elena Rodríguez-García
Laboratorio de Enfermedades Mitocondriales, Instituto de Investigación Hospital 12 de Octubre (i+12), Madrid, Spain
5 shared publications - Francisco Javier Cotrina-Vinagre
Grupo de Enfermedades Raras, Mitocondriales y Neuromusculares (ERMN), Instituto de Investigación Hospital 12 de Octubre (imas12), Madrid, Spain
4 shared publications - Angelita Rebollo
Unité de Technologies Chimiques et Biologiques pour la Santé, INSERM U1267 - CNRS UMR8258, Université Paris Cité, Faculté de Pharmacie, France
3 shared publications
Latest Publications
- Open Access
- 17 September 2026
- Published by Springer Nature in BMC Pediatrics
Persistent normality on serial cranial ultrasound as a marker of early developmental trajectory in preterm infants: a single-centre retrospective cohort study
- 17 September 2026
- Published by Springer Nature in BMC Pediatrics
Open AccessPersistent normality on serial cranial ultrasound as a marker of early developmental trajectory in preterm infants: a single-centre retrospective cohort study
- Open Access
Three-Domain Serial Cranial Ultrasound Phenotypes and Outcomes in Very Preterm Infants with Severe Brain Injury: A Single-Center Cohort Study
Background/Objectives: Severe brain injury (SBI) in very preterm infants includes heterogeneous lesions with distinct timing, burden and outcomes. We used cranial ultrasound (CUS) to describe SBI entity, documented timing, three-domain burden, deaths following documented withdrawal, withholding or non-escalation of life-sustaining treatment for poor neurological prognosis (neuro-WWLST), and survivor outcomes. Methods: Retrospective single-center cohort (1991–2020) of 2841 very preterm infants (<32 weeks’ gestation and/or birth weight ≤ 1500 g) with complete CUS within 48 h after birth. CUS was summarized by four windows, three domains—parenchymal lesion, intraventricular hemorrhage (IVH) and ventriculomegaly—and three mutually exclusive entities: periventricular hemorrhagic infarction (PVHI), cystic periventricular leukomalacia (cPVL and grade 3 IVH without PVHI/cPVL (IVH3 entity). Cross-outcome analyses used common maximal-burden CUS. Results: SBI occurred in 286/2841 infants (10.1%) and neuro-WWLST death in 45/2841 infants (1.6%); 43/45 occurred within SBI, and 43/89 SBI deaths (48.3%) followed documented neuro-WWLST. Using common maximal-burden CUS, severe three-domain involvement was more frequent among neuro-WWLST deaths than survivors (37.2% vs. 8.6%). Among SBI survivors with follow-up, cerebral palsy (CP) occurred in 87/176 (49.4%) and clinically classified school-age cognitive sequelae in 50/155 (32.3%). Outcomes varied by entity, with mainly ambulatory unilateral CP after PVHI, more frequent non-ambulatory bilateral CP after cPVL, and a heterogeneous IVH3 profile. Severe three-domain involvement identified a small subgroup with higher outcome burden, but outcomes were not deterministic. Conclusions: A structured, descriptive CUS approach separating lesion entity, documented timing and multidomain burden may support transparent cohort-level description of SBI trajectories, documented neuro-WWLST deaths and survivor outcomes.
Open AccessThree-Domain Serial Cranial Ultrasound Phenotypes and Outcomes in Very Preterm Infants with Severe Brain Injury: A Single-Center Cohort Study
Background/Objectives: Severe brain injury (SBI) in very preterm infants includes heterogeneous lesions with distinct timing, burden and outcomes. We used cranial ultrasound (CUS) to describe SBI entity, documented timing, three-domain burden, deaths following documented withdrawal, withholding or non-escalation of life-sustaining treatment for poor neurological prognosis (neuro-WWLST), and survivor outcomes. Methods: Retrospective single-center cohort (1991–2020) of 2841 very preterm infants (<32 weeks’ gestation and/or birth weight ≤ 1500 g) with complete CUS within 48 h after birth. CUS was summarized by four windows, three domains—parenchymal lesion, intraventricular hemorrhage (IVH) and ventriculomegaly—and three mutually exclusive entities: periventricular hemorrhagic infarction (PVHI), cystic periventricular leukomalacia (cPVL and grade 3 IVH without PVHI/cPVL (IVH3 entity). Cross-outcome analyses used common maximal-burden CUS. Results: SBI occurred in 286/2841 infants (10.1%) and neuro-WWLST death in 45/2841 infants (1.6%); 43/45 occurred within SBI, and 43/89 SBI deaths (48.3%) followed documented neuro-WWLST. Using common maximal-burden CUS, severe three-domain involvement was more frequent among neuro-WWLST deaths than survivors (37.2% vs. 8.6%). Among SBI survivors with follow-up, cerebral palsy (CP) occurred in 87/176 (49.4%) and clinically classified school-age cognitive sequelae in 50/155 (32.3%). Outcomes varied by entity, with mainly ambulatory unilateral CP after PVHI, more frequent non-ambulatory bilateral CP after cPVL, and a heterogeneous IVH3 profile. Severe three-domain involvement identified a small subgroup with higher outcome burden, but outcomes were not deterministic. Conclusions: A structured, descriptive CUS approach separating lesion entity, documented timing and multidomain burden may support transparent cohort-level description of SBI trajectories, documented neuro-WWLST deaths and survivor outcomes.
- 4 December 2025
- Published by Taylor & Francis in Ocular Immunology and Inflammation
- Vol. 34 (1) , 202-205
Posterior Scleritis in a Pediatric Patient with IgA Vasculitis
To report a boy with IgA vasculitis (IgAV), who suffered two episodes of Posterior Scleritis (PS). This is the first reported case of this association. Case report based on medical record review. A 13-year-old boy with IgAV presented with left eye (LE) pain. Although the eye examination was unremarkable, Magnetic resonance imaging (MRI) revealed PS; appropriate treatment was initiated, resulting in an excellent response. Later, a similar episode occurred in the right eye (RE) accompanied by a violaceus papule on the tip of the nose. PS may be associated with IgAV in children. MRI was crucial to detect the PS in this case. Nonsteroidal anti-inflammatory drugs (NSAIDs) were effective first-line treatment.
- 4 December 2025
- Published by Taylor & Francis in Ocular Immunology and Inflammation
- Vol. 34 (1) , 202-205
Posterior Scleritis in a Pediatric Patient with IgA Vasculitis
To report a boy with IgA vasculitis (IgAV), who suffered two episodes of Posterior Scleritis (PS). This is the first reported case of this association. Case report based on medical record review. A 13-year-old boy with IgAV presented with left eye (LE) pain. Although the eye examination was unremarkable, Magnetic resonance imaging (MRI) revealed PS; appropriate treatment was initiated, resulting in an excellent response. Later, a similar episode occurred in the right eye (RE) accompanied by a violaceus papule on the tip of the nose. PS may be associated with IgAV in children. MRI was crucial to detect the PS in this case. Nonsteroidal anti-inflammatory drugs (NSAIDs) were effective first-line treatment.
- 9 October 2024
- Published by Elsevier in European Journal of Paediatric Neurology
- Vol. 53, 95-103
Multicentric Pediatric Stroke Code: Insight to the first years after implementation
- 9 October 2024
- Published by Elsevier in European Journal of Paediatric Neurology
- Vol. 53, 95-103
Multicentric Pediatric Stroke Code: Insight to the first years after implementation
- 1 July 2022
- Published by Wiley in Human Mutation
- Vol. 43 (10) , 1361-1367
First splicing variant in HECW2 with an autosomal recessive pattern of inheritance and associated with NDHSAL
We report the clinical and genetic features of a Caucasian girl who presented a severe neurodevelopmental disorder with drug-resistant epilepsy, hypotonia, severe gastro-esophageal reflux and brain magnetic resonance imaging anomalies. WES uncovered a novel variant in homozygosis (g.197092814_197092824delinsC) in HECW2 gene that encodes the E3 ubiquitin-protein ligase HECW2. This protein induces ubiquitination and is implicated in the regulation of several important pathways involved in neurodevelopment and neurogenesis. Furthermore, de novo heterozygous missense variants in this gene have been associated with neurodevelopmental disorder with hypotonia, seizures, and absent language (NDHSAL). The homozygous variant of our patient disrupts the splice donor site of intron 22 and causes the elimination of exon 22 (r.3766_3917+1del) leading to an in-frame deletion of the protein (p.Leu1256_Trp1306del). Functional studies showed a twofold increase of its RNA expression, while the protein expression level was reduced by 60%, suggesting a partial loss-of-function mechanism of pathogenesis. Thus, this is the first patient with NDHSAL caused by an autosomal recessive splicing variant in HECW2.
- 1 July 2022
- Published by Wiley in Human Mutation
- Vol. 43 (10) , 1361-1367
First splicing variant in HECW2 with an autosomal recessive pattern of inheritance and associated with NDHSAL
We report the clinical and genetic features of a Caucasian girl who presented a severe neurodevelopmental disorder with drug-resistant epilepsy, hypotonia, severe gastro-esophageal reflux and brain magnetic resonance imaging anomalies. WES uncovered a novel variant in homozygosis (g.197092814_197092824delinsC) in HECW2 gene that encodes the E3 ubiquitin-protein ligase HECW2. This protein induces ubiquitination and is implicated in the regulation of several important pathways involved in neurodevelopment and neurogenesis. Furthermore, de novo heterozygous missense variants in this gene have been associated with neurodevelopmental disorder with hypotonia, seizures, and absent language (NDHSAL). The homozygous variant of our patient disrupts the splice donor site of intron 22 and causes the elimination of exon 22 (r.3766_3917+1del) leading to an in-frame deletion of the protein (p.Leu1256_Trp1306del). Functional studies showed a twofold increase of its RNA expression, while the protein expression level was reduced by 60%, suggesting a partial loss-of-function mechanism of pathogenesis. Thus, this is the first patient with NDHSAL caused by an autosomal recessive splicing variant in HECW2.
- 11 August 2020
- Published by Wolters Kluwer Health in Neurology
- Vol. 95 (17) , e2460-e2461
Teaching Video NeuroImages: Congenital mirror movements
- 11 August 2020
- Published by Wolters Kluwer Health in Neurology
- Vol. 95 (17) , e2460-e2461
Teaching Video NeuroImages: Congenital mirror movements
- Open Access
- 1 April 2020
- Published by Elsevier in Anales de Pediatría
- Vol. 92 (4) , 245-246
Malformación congénita de seno dural con resolución espontánea
- 1 April 2020
- Published by Elsevier in Anales de Pediatría
- Vol. 92 (4) , 245-246
Open AccessMalformación congénita de seno dural con resolución espontánea
- 21 March 2020
- Published by Wiley in American Journal of Medical Genetics Part A
- Vol. 182 (6) , 1483-1490
MAST1 variant causes mega‐corpus‐callosum syndrome with cortical malformations but without cerebellar hypoplasia
We report the case of a Caucasian Spanish origin female who showed severe psychomotor developmental delay, hypotonia, strabismus, epilepsy, short stature, and poor verbal language development. Brain magnetic resonance imaging scans showed thickened corpus callosum, cortical malformations, and dilated and abnormal configuration of the lateral ventricles without hydrocephalus. Whole‐exome sequence uncovered a de novo variant in the microtubule associated serine/threonine kinase 1 gene (MAST1; NM_014975.3:c.1565G>A:p.(Gly522Glu)) that encodes for the MAST1. Only 12 patients have been identified worldwide with 10 different variants in this gene: six patients with mega‐corpus‐callosum syndrome with cerebellar hypoplasia and cortical malformations; two patients with microcephaly and cerebellar hypoplasia; two patients with autism, one patient with diplegia, and one patient with microcephaly and dysmorphism. Our patient shows a new phenotypic subtype defined by mega‐corpus‐callosum syndrome with cortical malformations without cerebellar hypoplasia. In conclusion, our data expand the phenotypic spectrum associated to MAST1 gene variants.
- 21 March 2020
- Published by Wiley in American Journal of Medical Genetics Part A
- Vol. 182 (6) , 1483-1490
MAST1 variant causes mega‐corpus‐callosum syndrome with cortical malformations but without cerebellar hypoplasia
We report the case of a Caucasian Spanish origin female who showed severe psychomotor developmental delay, hypotonia, strabismus, epilepsy, short stature, and poor verbal language development. Brain magnetic resonance imaging scans showed thickened corpus callosum, cortical malformations, and dilated and abnormal configuration of the lateral ventricles without hydrocephalus. Whole‐exome sequence uncovered a de novo variant in the microtubule associated serine/threonine kinase 1 gene (MAST1; NM_014975.3:c.1565G>A:p.(Gly522Glu)) that encodes for the MAST1. Only 12 patients have been identified worldwide with 10 different variants in this gene: six patients with mega‐corpus‐callosum syndrome with cerebellar hypoplasia and cortical malformations; two patients with microcephaly and cerebellar hypoplasia; two patients with autism, one patient with diplegia, and one patient with microcephaly and dysmorphism. Our patient shows a new phenotypic subtype defined by mega‐corpus‐callosum syndrome with cortical malformations without cerebellar hypoplasia. In conclusion, our data expand the phenotypic spectrum associated to MAST1 gene variants.
- 10 January 2020
- Published by Springer Nature in Journal of Genetics
- Vol. 99 (1) , 1-5
A novel de novo mutation in the PURA gene associated with a new clinical finding: large brainstem
We report the case of a Caucasian Spanish boy, who showed profound neonatal hypotonia, feeding difficulties, apnea, severe developmental delay, epilepsy, bilateral convergent strabismus, poor verbal language development and a large brainstem. Whole-exome sequence uncovered a novel de novo mutation in the purine-rich element binding protein A gene (PURA; NM_005859.4:c.72del:p.(Gly25AlafsTer53)) that encodes the transcriptional activator protein Pur-alpha (PURA). Mutations in this gene have been identified in patients with PURA syndrome, a rare disorder characterized by an early hypotonia, developmental delay, severe intellectual disability with or without epilepsy, and disability in expressive language development. Although, up to 75 cases have been identified worldwide, to the best of our knowledge, this is the first patient described with a brainstem larger than normal. In conclusion, our data expand both genetic and phenotypic spectrum associated with PURA gene mutations.
- 10 January 2020
- Published by Springer Nature in Journal of Genetics
- Vol. 99 (1) , 1-5
A novel de novo mutation in the PURA gene associated with a new clinical finding: large brainstem
We report the case of a Caucasian Spanish boy, who showed profound neonatal hypotonia, feeding difficulties, apnea, severe developmental delay, epilepsy, bilateral convergent strabismus, poor verbal language development and a large brainstem. Whole-exome sequence uncovered a novel de novo mutation in the purine-rich element binding protein A gene (PURA; NM_005859.4:c.72del:p.(Gly25AlafsTer53)) that encodes the transcriptional activator protein Pur-alpha (PURA). Mutations in this gene have been identified in patients with PURA syndrome, a rare disorder characterized by an early hypotonia, developmental delay, severe intellectual disability with or without epilepsy, and disability in expressive language development. Although, up to 75 cases have been identified worldwide, to the best of our knowledge, this is the first patient described with a brainstem larger than normal. In conclusion, our data expand both genetic and phenotypic spectrum associated with PURA gene mutations.
- 1 November 2019
- Published by Wolters Kluwer Health in The Pediatric Infectious Disease Journal
- Vol. 38 (11) , 1131-1137
Role of Magnetic Resonance Imaging and Cranial Ultrasonography in Congenital Cytomegalovirus Infection
- 1 November 2019
- Published by Wolters Kluwer Health in The Pediatric Infectious Disease Journal
- Vol. 38 (11) , 1131-1137
Role of Magnetic Resonance Imaging and Cranial Ultrasonography in Congenital Cytomegalovirus Infection